UBS, New York Branch
Lily guides biotechnology companies in the negotiation of complex product development and commercialization transactions. She advises early and mid-stage companies, many in the cell and gene-therapy space and assists drug sponsors and contract development and manufacture organizations in the negotiation of clinical and commercial manufacturing and supply arrangements.
Lily also represents public and private companies in strategic collaborations, product licensing, and distribution and co-promotion agreements.
New York Branch of UBS
Director and Counsel
Simpson Thacher & Bartlett
Corporate Department Associate
Sidley Austin
Member of business transactions group